Speedy clinical trials to be available

Clinicians will be able to conduct their clinical trials in a prompt manner with the proposed introduction of a joint institutional review board (IRB), according to the Korea Food and Drug Administration.

To that end, the KFDA said on January 19 it will legislate to revise the current rules concerning clinical trials of drugs.

Under the new regulation, a joint IRB meeting may be held base...